EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pancreatic serous cystadenoma with a high 68 Ga DOTATOC-uptake mimicking a pancreatic NET

Erling A Bringeland, Elin Rønne, Åse Kjellmo, Thomas M Keil

International Journal of Hepatobiliary and Pancreatic Diseases · 2022

DOI: 10.5348/100097z04eb2022eb ↗
AbstractBibliografische Angaben

Abstract

Introduction: 68Ga-DOTATOC positron emission tomography (PET) has replaced octreotide scintigraphy as method of choice in detecting and staging most neuroendocrine tumors (NETs). With a better signal-to-noise ratio and improved spatial resolution, sensitivity is increased. However, several non-NETs express surface somatostatin receptors, challenging the positive predictive value of a DOTATOC scan regarding a NET diagnosis. This is of particular concern in pancreas as NET is a frequent differential diagnosis, as is a variety of cystic neoplasms increasingly often diagnosed as incidental findings. Case Report: A 66-year-old man was diagnosed with an asymptomatic cystic tumor in the pancreatic neck. At computed tomography scan (CT) a 4 cm P-NET was suspected as an incidental finding. The diagnosis was supported by a positive 68Ga-DOTATOC scan, with a high DOTATOC-uptake in the pancreatic tumor and in a local interaortocaval node. The tumor was radically resected. At pathologic examination a pancreatic serous cystadenoma (SCN) was unexpectedly diagnosed, with the regional nodes proven only to harbor granulomatous inflammation. Conclusion: A rare case of a 68Ga-DOTATOC positive SCN is reported. Diagnostic workup was confounded by a local node exhibiting a high DOTATOC-uptake. Radiologists, nuclear medicine physicians, and pancreatic surgeons must be aware of this diagnostic pitfall to avoid unnecessary surgical procedures.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →